Omnicare acquires excelleRx for $269M

Omnicare has agreed to buy excelleRx for $269 million in a move aimed at absorbing the company's technology and call center for pharmaceutical services. Philadelphia-based excelleRx provides pharmaceutical products and care services for hospices.

- read this press release for more